Kolexia
Urban Thierry
Pneumologie
Hôpital Larrey Angers
Angers, France
155 Activités
21 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Fibrose Maladies pulmonaires Mésothéliome Mésothéliome malin Syndrome d'apnées obstructives du sommeil Adénocarcinome

Industries

Sanofi
21 collaboration(s)
Dernière en 2023
AstraZeneca
17 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
8 collaboration(s)
Dernière en 2023
BMS
6 collaboration(s)
Dernière en 2021

Dernières activités

Synthetic cannabinoid overdose: Watch out for acute respiratory complications.
Revue des maladies respiratoires   08 mars 2024
MELROSE: Phase 2 Study Evaluating MEchanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtinib Until and Beyond Radiological Progression : the MELROSE Trial
Essai Clinique (AstraZeneca)   26 février 2024
A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).
Cancers   06 décembre 2023
Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients.
Critical care (London, England)   06 novembre 2023
Prevalence and severity of functional urinary and anorectal disorders and their impact on quality of life in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   29 octobre 2023
Safety and tolerability of weekly docetaxel plus nintedanib: A phase I trial after first-line chemotherapy failure in NSCLC.
PloS one   17 octobre 2023
1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
And if we wagered that 10 years from now, there will be no new "lungs and addictives substances" series in the Revue des Maladies Respiratoires?.
Revue des maladies respiratoires   14 juin 2023
Diffuse alveolar hemorrhage in cannabis smokers. A systematic literature review.
Revue des maladies respiratoires   20 avril 2023
DURVALUNG: A Phase II Study of Durvalumab (MEDI 4736) Maintenance in Frail Limited Disease Small Cell Lung Cancer Patients After Thoracic Chemoradiotherapy (CRT)
Essai Clinique (AstraZeneca)   27 mars 2023